previous compound ID: 2035 next compound
InChIKey: RXPRRQLKFXBCSJ-GIVPXCGWSA-N
SMILES: CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4[C@](C2)(C(=O)OC)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "GW Carlile" "J Goepp" "JW Hanrahan" "E Matthes" "D Rotin" "J Liao" "R Robert" "B Kus" "SD Macknight"

chemical graph of compound 2035





CID is 15376
synonyms found at PubChem are:
vincamine, 1617-90-9, Pervincamine, Devincan, Minorine, Vincamidol, Monorin, Novicet, Methyl vincaminate, Arteriovinca, Vincasaunier, (+)-Vincamine, Anasclerol, Angiopac, Decincan, Devinkan, Tripervan, Vincadar, Vincafolina, Vincapront, Vinkametrin, Equipur, Oxygeron, Pervone, Vincafor, Perval, Ocu-vinc, Vincamina [DCIT], Vincimax, Vincamine base, Vincaminum [INN-Latin], UNII-996XVD0JHT, Vincamine [INN:BAN:DCF], Minorin, Vincachron, Vincagil, Vincamin, Vincapan, Vinca, Vinodrel retard, Vinca-Ecobi, Vinca-Minor, HSDB 7150, Anasclerol (base), EINECS 216-576-3, NSC 91998, 996XVD0JHT, CHEBI:9985, RXPRRQLKFXBCSJ-GIVPXCGWSA-N, Alkaloid obtained from Vinca minor, Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16alpha)-, 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester, DSSTox_CID_20134, DSSTox_RID_79448, Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16.), DSSTox_GSID_40134, Cerebroxine, Vincaminum, Vincamina, methyl 14beta-hydroxy-14,15-dihydro-3alpha,16alpha-eburnamenine-14alpha-carboxylate, Teprosilic Acid, (3?,14?,16?)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester, Vincamine (FP), NCGC00094824-01, Vincamine (INN), Prestwick_495, CAS-1617-90-9, Cetal retard (TN), Vincamine, 98%, Prestwick0_000271, Prestwick1_000271, Prestwick2_000271, Prestwick3_000271, Vincamine, 98% 1g, D08UGJ, AC1L25RL, BSPBio_000142, GTPL349, MLS002154249, SCHEMBL147179, SPBio_002361, BPBio1_000158, CHEMBL1165342, DTXSID9040134, BCBcMAP01_000080, MolPort-002-510-941, HMS1568H04, HMS2095H04, HMS2268C20, HMS3712H04, BCP05837, HY-B1021, ZINC1069082, Tox21_111342, Tox21_301968, MFCD00078054, AKOS015896471, Tox21_111342_1, API0004593, CCG-208544, CS-4536, DB13374, EBD2197880, KS-5179, SMP1_000314, Vincamine, analytical reference material, NCGC00184983-01, NCGC00184983-03, NCGC00255542-01, AC-22625, AK163212, AN-49543, BC681377, SC-19228, SMR000112509, AX8156430, LS-162175, ST24050348, C09251, D08677, J10447, 617V909, I06-1879, Q-100193, BRD-K40902647-001-03-7, methyl (3alpha,14beta,16alpha)-14-hydroxy-14,15-dihydroeburnamenine-14-carboxylate, Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-,methyl ester, (3alpha,14beta,16alpha)-, methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0?,?.0?,??.0??,??]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate, methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate